Marc S. Lener
Marc S. Lener
National Institute of Mental Health
Dirección de correo verificada de
Citado por
Citado por
Glutamate and gamma-aminobutyric acid systems in the pathophysiology of major depression and antidepressant response to ketamine
MS Lener, MJ Niciu, ED Ballard, M Park, LT Park, AC Nugent, ...
Biological psychiatry 81 (10), 886-897, 2017
Ketamine for rapid reduction of suicidal ideation: a randomized controlled trial
JW Murrough, L Soleimani, KE DeWilde, KA Collins, KA Lapidus, ...
Psychological medicine 45 (16), 3571-3580, 2015
Ketamine and Beyond: Investigations into the Potential of Glutamatergic Agents to Treat Depression.
ZC Lener MS, Kadriu B
Drugs, 2017
In pursuit of neuroimaging biomarkers to guide treatment selection in major depressive disorder: a review of the literature
MS Lener, DV Iosifescu
Annals of the New York Academy of Sciences 1344 (1), 50-65, 2015
White matter abnormalities in schizophrenia and schizotypal personality disorder
MS Lener, E Wong, CY Tang, W Byne, KE Goldstein, NJ Blair, ...
Schizophrenia bulletin 41 (1), 300-310, 2015
Parsing the heterogeneity of depression: An exploratory factor analysis across commonly used depression rating scales
ED Ballard, JS Yarrington, CA Farmer, MS Lener, B Kadriu, N Lally, ...
Journal of Affective Disorders 231, 51-57, 2018
Handedness, heritability, neurocognition and brain asymmetry in schizophrenia
A Deep-Soboslay, TM Hyde, JP Callicott, MS Lener, BA Verchinski, ...
Brain 133 (10), 3113-3122, 2010
Acute ketamine administration corrects abnormal inflammatory bone markers in major depressive disorder
B Kadriu, PW Gold, DA Luckenbaugh, MS Lener, ED Ballard, MJ Niciu, ...
Molecular psychiatry 23 (7), 1626-1631, 2018
Cortical abnormalities and association with symptom dimensions across the depressive spectrum
MS Lener, P Kundu, E Wong, KE Dewilde, CY Tang, P Balchandani, ...
Journal of affective disorders 190, 529-536, 2016
Neurophysiological changes associated with antidepressant response to ketamine not observed in a negative trial of scopolamine in major depressive disorder
L Park, M Furey, AC Nugent, C Farmer, J Ellis, J Szczepanik, MS Lener, ...
International Journal of Neuropsychopharmacology 22 (1), 10-18, 2019
Frontal release signs and cognition in people with schizophrenia, their siblings and healthy controls
TM Hyde, TE Goldberg, MF Egan, MC Lener, DR Weinberger
The British Journal of Psychiatry 191 (2), 120-125, 2007
A double-blind, placebo-controlled, pilot study of riluzole monotherapy for acute bipolar depression
LT Park, MS Lener, M Hopkins, N Iadorola, R Machado-Vieira, E Ballard, ...
Journal of clinical psychopharmacology 37 (3), 355-358, 2017
The antidepressant efficacy of subanesthetic-dose ketamine does not correlate with baseline subcortical volumes in a replication sample with major depressive disorder
MJ Niciu, ND Iadarola, D Banerjee, DA Luckenbaugh, M Park, M Lener, ...
Journal of Psychopharmacology 31 (12), 1570-1577, 2017
The effects of ketamine on typical and atypical depressive symptoms
LT Park, DA Luckenbaugh, SJ Pennybaker, MA Hopkins, ID Henter, ...
Acta Psychiatrica Scandinavica 142 (5), 394-401, 2020
RGS4 and COMT risk variants are associated with brain structural alterations
MS Lener, SJ Goodnow, JA Wood, KV Chowdari, MS Keshavan, ...
Schizophrenia research 150 (1), 321-322, 2013
330. A Principal Components Analysis of Depression and Anhedonia Scales: Illustrating the Heterogeneity of Depression
E Ballard, D Luckenbaugh, J Yarrington, N Lally, M Lener, ...
Biological Psychiatry 81 (10), S135, 2017
Clinical trial of the potassium channel activator diazoxide for major depressive disorder halted due to intolerability
B Kadriu, S Yuan, C Farmer, AC Nugent, MS Lener, MJ Niciu, M Park, ...
Journal of clinical psychopharmacology 38 (3), 243, 2018
RETRACTED: F173. Negative Trial of Scopolamine in Major Depressive Disorder Does Not Demonstrate Neurophysiological Changes Seen With the Antidepressant Response of Ketamine
L Park, M Furey, A Nugent, C Farmer, J Ellis, J Szczepanik, M Lener, ...
Biological Psychiatry 83 (9), S305-S306, 2018
1003. Acute Ketamine Administration Corrects Abnormal Inflammatory Bone Markers in Major Depression
B Kadriu, P Gold, M Lener, E Ballard, M Niciu, P Yuan, D Luckenbaugh, ...
Biological Psychiatry 81 (10), S405-S406, 2017
517. Effects of Ketamine on Atypical and Typical Symptoms of Depression
K Yu, L Park, D Luckenbaugh, S Pennybaker, M Hopkins, M Lener, ...
Biological Psychiatry 81 (10), S210, 2017
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20